Radiation protection in radionuclide therapies with 90Y- conjugates: Risks and safety

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 11, 2006, Pages 1321-1327

  Cremonesi, Marta ^a   Ferrari, Mahila ^a   Paganelli, Giovanni ^a   Rossi, Annalisa ^a   Chinol, Marco ^a   Bartolomei, Mirco ^a   Prisco, Gennaro ^a   Tosi, Giampiero ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

90Y radiolabelling; 90Y radiopharmaceuticals; Fingertip dosimetry; Optimisation; Radiation protection

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID, TYROSINE OCTREOTIDE Y 90; IBRITUMOMAB TIUXETAN; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTICLE; CONTROLLED STUDY; HOSPITAL PERSONNEL; HOSPITALIZATION; HUMAN; IRRADIATION; ISOTOPE LABELING; PATIENT SAFETY; PROTECTIVE CLOTHING; RADIATION DOSE; RADIATION PROTECTION; RISK FACTOR;

ITALY; MEDICAL STAFF, HOSPITAL; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; RADIATION DOSAGE; RADIATION MONITORING; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; YTTRIUM RADIOISOTOPES;

EID: 33750287583     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0151-1     Document Type: Article

References (19)

1. Delacroix D, Guerre JP, Leblanc P, Hickman C. Radionuclide and radiation protection data handbook 2002, 2nd edition. Rad Prot Dos 2002;98:1-168
2. 90Y-DOTATOC) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2004;31:1038-1046
3. 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging 2002;29:486-493
4. Paganelli G, Grana C, Chinol M, Cremonesi M, De Cicco C, De Braud F, et al. Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med Mol Imaging 1999;26:348-357
5. Witzig TE, Flinn IW, Gordon LI, Emmanouilides C, Czuczman MS, Saleh MN, et al. Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma. J Clin Oncol 2002;20:3262-3269
6. 90Y-labeled anti-CD20 monoclonal antibody. J Nucl Med 2002;43:267-272
7. Tosi G. Report on one accident occurred in a nuclear medicine department in Italy. In: Proceedings of the 6th European ALARA Network workshop. Occupational Exposure Optimisation in the Medical Field and Radiopharmaceutical Industry. Sponsored by the European Commission Radiation protection. Madrid; 2002;225
8. Salako QA, DeNardo SJ. Radioassay of yttrium-90 radiation using the radionuclide dose calibrator. J Nucl Med 1997;38:723-726
9. 90Y-ibritumomab tiuxetan. J Nucl Med 2004;45:450-454
10. Zimmerman BE, Cessna JT. Experimental determinations of commercial 'dose calibrator' settings for nuclides used in nuclear medicine. Appl Radiat Isot 2000;52:615-619
11. Council Directive 97/43/Euratom 1997 on health protection of individuals against the dangers of ionising radiation in relation to medical exposure. Available on http://europa.eu.int/comm/energy/nuclear/radioprotection/doc/ legislation/9743_en.pdf
12. Actuation of the Council Directive 97/43/Euratom 1997 in the Italian regulation (Decreto Legislativo 26 maggio 2000, n. 187. Attuazione della direttiva 97/43/EURATOM in materia di protezione sanitaria delle persone contro i pericoli delle radiazioni ionizzanti connesse ad esposizioni mediche). Available on http://www.camera.it/ parlam/leggi/deleghe/testi/00187dl.htm
13. Zanzonico PB, Binkert BL, Goldsmith SJ. Bremsstrahlung radiation exposure from pure beta-ray emitters. J Nucl Med 1999;40:1024-1028
14. 90Y. In: Proceedings of the 6th European ALARA Network workshop. Occupational Exposure Optimisation in the Medical Field and Radiopharmaceutical Industry. Sponsored by the European Commission Radiation protection. Madrid 2002;47-49
15. Sarfaraz M, Kennedy AS, Cao ZJ, Sackett GD, Yu CX, Lodge MA, et al. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 2003;30:199-203
16. Stabin M, Siegel J, Lipsztein J, Hunt J, Brill A, Sparks R, et al. RADAR (RAdiation Dose Assessment Resource). http://www.doseinfo-radar.com; http://www.ieo.it/radar
17. Saether HK, Davidson TM, Widmark A, Wohni T. Measurements of finger doses in x-ray guided surgery, nuclear medicine and research. Radiat Prot Dosimetry 2005;113:392-395
18. Cremonesi M, Ferrari M, Sacco E, Rossi A, Leonardi L, Chinol M, et al. Radiation protection in radioguided surgery of breast cancer. Nucl Med Commun 1999;20:919-925
19. Release of patients after therapy with unsealed radionuclides. International Commission on Radiological Protection, ICRP Publication 94, 2005. http://www.elsevier.com